Pyridazines as interleukin-1&bgr; converting enzyme inhibitors
    7.
    发明授权
    Pyridazines as interleukin-1&bgr; converting enzyme inhibitors 失效
    哒嗪作为白细胞介素-1β转换酶抑制剂

    公开(公告)号:US06624166B1

    公开(公告)日:2003-09-23

    申请号:US08625680

    申请日:1996-04-03

    IPC分类号: C07D23724

    摘要: Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R1 is a halogen, or an oxygen linked leaving group including an aromatic ether, an alkyl sulfonate, an aryl sulfonate, an alkyl phosphonate, an aryl phosphonate, an alkyl phosphate or aryl phosphate; R2 is COOR5, C(═O)NH(CHR5)m—COOR5, NH(CHR5)mCON(R5)R6, C(═O)N(R5)R6 or NH(CHR5)mOH; R3 is H or alkyl; R4 is H, sybstituted or unsubstituted aryl, heteroaryl or alkyl; R5 and R6 are independently H, lower alkyl, aryl, hydroxy alkyl, amino alkyl, heteroaryl, lower alkylene-aryl, lower alkylene-heteroaryl or lower cycloalkyl; and m=0-6; pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1&bgr; protease activity in a mammal utilizing the compounds and compositions.

    摘要翻译: 公开了式(I)的化合物及其药学上可接受的盐:其中R1是卤素或含有芳香醚,烷基磺酸酯,芳基磺酸酯,烷基膦酸酯,芳基膦酸酯,磷酸烷基酯 或芳基磷酸酯; R2是COOR5,C(= O)NH(CHR5)m -COOR5,NH(CHR5)mCON(R5)R6,C(= O)N(R5)R6或NH(CHR5) H或烷基; R 4是H,取代或未取代的芳基,杂芳基或烷基; R 5和R 6独立地是H,低级烷基,芳基,羟基烷基,氨基烷基,杂芳基,低级亚烷基 - 芳基,低级亚烷基 - 杂芳基或低级环烷基; m = 0-6; 含有这些化合物的药物组合物; 以及利用该化合物和组合物抑制哺乳动物中白细胞介素-1β蛋白酶活性的方法。

    Pyridazines as interleukin-1.beta. converting enzyme inhibitors
    8.
    发明授权
    Pyridazines as interleukin-1.beta. converting enzyme inhibitors 失效
    哒嗪作为白细胞介素-1β转换酶抑制剂

    公开(公告)号:US6121266A

    公开(公告)日:2000-09-19

    申请号:US444984

    申请日:1995-05-19

    摘要: Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is a halogen, or an oxygen linked leaving group including an aromatic ether, an alkyl sulfonate, an aryl sulfonate, an alkyl phosphonate, an aryl phosphonate, an alkyl phosphate or aryl phosphate;R.sub.2 is COOR.sub.5, C(.dbd.O)NH(CHR.sub.5).sub.m --COOR.sub.5, NH(CHR.sub.5).sub.m CON(R.sub.5)R.sub.6, C(.dbd.O)N(R.sub.5)R.sub.6 or NH(CHR.sub.5).sub.m OH;R.sub.3 is H or alkyl;R.sub.4 is H, substituted or unsubstituted aryl, heteroaryl or alkyl;R.sub.5 and R.sub.6 are independently H, lower alkyl, aryl, hydroxy alkyl, amino alkyl, heteroaryl, lower alkylene-aryl, lower alkylene-heteroaryl or lower cycloalkyl; and m=0-6; pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1.beta. protease activity in a mammal utilizing the compounds and compositions.

    摘要翻译: 公开了式(I)的化合物及其药学上可接受的盐:其中R1是卤素,或含有芳香族醚,烷基磺酸酯,芳基磺酸酯,烷基膦酸酯,芳基膦酸酯,烷基 磷酸盐或芳基磷酸盐; R2是COOR5,C(= O)NH(CHR5)m -COOR5,NH(CHR5)mCON(R5)R6,C(= O)N(R5)R6或NH(CHR5) R3是H或烷基; R4是H,取代或未取代的芳基,杂芳基或烷基; R5和R6独立地为H,低级烷基,芳基,羟基烷基,氨基烷基,杂芳基,低级亚烷基 - 芳基,低级亚烷基 - 杂芳基或低级环烷基; m = 0-6; 含有这些化合物的药物组合物; 以及利用该化合物和组合物抑制哺乳动物中白细胞介素-1β蛋白酶活性的方法。